Regavirumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | cytomegalovirus glycoprotein B |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 153101-26-9 |
ChemSpider | none |
(what is this?) (verify) |
Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]
References
- ↑ Arizono, H; Sugano, T; Kaida, S; Shibusawa, K; Karasawa, Y; Esumi, Y; Kondo, S; Kiyoki, M (1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.
This article is issued from Wikipedia - version of the 10/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.